{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:03:32Z","timestamp":1786989812344,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,29]],"date-time":"2026-12-29T00:00:00Z","timestamp":1798502400000},"content-version":"am","delay-in-days":362,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030847","name":"Georgia Tech 3D Systems Packaging Research Center","doi-asserted-by":"publisher","award":["R21AA030372"],"award-info":[{"award-number":["R21AA030372"]}],"id":[{"id":"10.13039\/100030847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.genhosppsych.2025.12.019","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T07:18:02Z","timestamp":1766819882000},"page":"159-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Challenges of enrolling participants with alcohol and opioid use disorders in the emergency department for clinical trials of ketamine: The experience from two randomized controlled trials"],"prefix":"10.1016","volume":"98","author":[{"given":"P.R.","family":"Chai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Hasdianda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Goldfine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.genhosppsych.2025.12.019_bb0005","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s00127-015-1088-0","article-title":"The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) waves 1 and 2: review and summary of findings","volume":"50","author":"Hasin","year":"2015","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"10.1016\/j.genhosppsych.2025.12.019_bb0010","article-title":"The therapeutic use and efficacy of ketamine in alcohol use disorder and alcohol withdrawal syndrome: a scoping review","volume":"14","author":"Goldfine","year":"2023","journal-title":"Front Psych"},{"key":"10.1016\/j.genhosppsych.2025.12.019_bb0015","article-title":"Ketamine in treating opioid use disorder and opioid withdrawal: a scoping review","volume":"16","author":"Shen","year":"2025","journal-title":"Front Psych"},{"key":"10.1016\/j.genhosppsych.2025.12.019_bb0020","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1007\/s11606-021-07069-w","article-title":"National prevalence of alcohol and other substance use disorders among emergency department visits and hospitalizations: NHAMCS 2014-2018","volume":"37","author":"Suen","year":"2022","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.genhosppsych.2025.12.019_bb0025","author":"Drug Abuse Warning Network"},{"key":"10.1016\/j.genhosppsych.2025.12.019_bb0030","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1176\/appi.ajp.2020.20081251","article-title":"Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation","volume":"178","author":"McIntyre","year":"2021","journal-title":"AJP"},{"key":"10.1016\/j.genhosppsych.2025.12.019_bb0035","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","article-title":"The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis","volume":"175","author":"Wilkinson","year":"2018","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.12.019_bb0040","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1176\/appi.ajp.2021.21030277","article-title":"Adjunctive ketamine with relapse prevention-based psychological therapy in the treatment of alcohol use disorder","volume":"179","author":"Grabski","year":"2022","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.12.019_bb0045","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.drugalcdep.2007.09.001","article-title":"Researching the intoxicated: informed consent implications for alcohol and drug research","volume":"93","author":"Aldridge","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.genhosppsych.2025.12.019_bb0050","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/2168479018771682","article-title":"Ethical issues in research involving participants with opioid use disorder","volume":"52","author":"Anderson","year":"2018","journal-title":"Ther Innov Regul Sci"},{"key":"10.1016\/j.genhosppsych.2025.12.019_bb0055","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/acem.13673","article-title":"Study enrollment when \u201cpreconsent\u201d is utilized for a randomized clinical trial of two treatments for acute agitation in the emergency department","volume":"26","author":"Cole","year":"2019","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.genhosppsych.2025.12.019_bb0060","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.annemergmed.2014.09.027","article-title":"Including frequent emergency department users with severe alcohol use disorders in research: assessing capacity","volume":"65","author":"McCormack","year":"2015","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.genhosppsych.2025.12.019_bb0065","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1001\/archpsyc.64.8.966","article-title":"A new brief instrument for assessing decisional capacity for clinical research","volume":"64","author":"Jeste","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.12.019_bb0070","first-page":"237","article-title":"Mania following ketamine abuse","volume":"12","author":"Lu","year":"2016","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.genhosppsych.2025.12.019_bb0075","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archpsyc.1997.01830130077015","article-title":"Psychiatric and substance use comorbidity among treatment-seeking opioid abusers","volume":"54","author":"Brooner","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.12.019_bb0080","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S2215-0366(19)30222-6","article-title":"Psychiatric comorbidities in alcohol use disorder","volume":"6","author":"Castillo-Carniglia","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.12.019_bb0085","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0893-133X(94)00131-I","article-title":"Subanesthetic doses of ketamine stimulate psychosis in schizophrenia","volume":"13","author":"Lahti","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.genhosppsych.2025.12.019_bb0090","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1151\/spp053113","article-title":"Mood disorders and substance use disorder: a complex comorbidity","volume":"3","author":"Quello","year":"2005","journal-title":"Sci Pract Perspect"},{"key":"10.1016\/j.genhosppsych.2025.12.019_bb0095","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.24m15376","article-title":"Efficacy and safety of ketamine\/esketamine in bipolar depression in a clinical setting","volume":"85","author":"Santucci","year":"2024","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.12.019_bb0100","first-page":"420","article-title":"Real-world effectiveness of repeated ketamine infusions for treatment-resistant bipolar depression","volume":"21","author":"Fancy","year":"2023","journal-title":"Focus (Am Psychiatr Publ)"},{"key":"10.1016\/j.genhosppsych.2025.12.019_bb0105","series-title":"Misdiagnosis of bipolar disorder Psychiatry (Edgmont)","first-page":"57","volume":"3","author":"Singh","year":"2006"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834325002488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834325002488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T18:18:53Z","timestamp":1773944333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834325002488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":21,"alternative-id":["S0163834325002488"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2025.12.019","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges of enrolling participants with alcohol and opioid use disorders in the emergency department for clinical trials of ketamine: The experience from two randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"General Hospital Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2025.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}